Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Comprehensive analysis of liquid-liquid phase separation-related genes in prediction of breast cancer prognosis

View through CrossRef
Objective: Liquid-liquid phase separation (LLPS) is a functional unit formed by specific molecules. It lacks a membrane and has been reported to play a crucial role in tumor drug resistance and growth by regulating gene expression and drug distribution. However, whether LLPS could be used to predict cancer prognosis was not clear. This study aimed to construct a prognostic model for breast cancer based on LLPS-correlated genes (LCGs).Methods: LCGs were identified using the PhaSepDB, gene expression profile and clinical characteristics of breast cancer were obtained from TCGA and cBioportal. The PanCancer Atlas (TCGA) cohort was used as the training cohort to construct the prognostic model, while the Nature 2012 and Nat Commun 2016 (TCGA) cohort and GEO data were used as test cohort to perform external verification. Data analysis was performed with R4.2.0 and SPSS20.0.Results: We identified 140 prognosis-related LCGs (pLCGs) (p< 0.01) in all cohorts, 240 pLCGs (p< 0.01) in the luminal cohort, and 28 pLCGs (p< 0.05) in the triple-negative breast cancer (TNBC) cohort. Twelve genes in all cohorts (training cohort: 5/10-year ROC values were 0.76 and 0.77; verification cohort: 5/10-year ROC values were 0.61 and 0.58), eight genes in the luminal cohort (training cohort: 5/10-year ROC values were 0.79 and 0.75; verification cohort: 5/10-year ROC values were 0.62 and 0.62), and four genes in the TNBC cohort (training cohort: 5/10-year ROC values were 0.73 and 0.79; verification cohort: 5/10-year ROC values were 0.55 and 0.54) were screened out to construct the prognostic prediction model. The 17-gene risk-score was constructed in all cohorts (1/3/5-year ROC values were 0.88, 0.83, and 0.81), and the 11-gene risk-score was constructed in the luminal cohort (1/3/5-year ROC values were 0.67, 0.85 and 0.84), and the six-gene risk-score was constructed in the TNBC cohort (1/3/5-year ROC value were 0.87, 0.88 and 0.81). Finally, the risk-score and clinical factors were applied to construct nomograms in all cohorts (1/3/5-year ROC values were 0.89, 0.79 and 0.75, C-index = 0.784), in the luminal cohort (1/3/5-year ROC values were 0.84, 0.83 and 0.85, C-index = 0.803), and in the TNBC cohort (1/3/5-year ROC values were 0.95, 0.84 and 0.77, C-index = 0.847).Discussion: This study explored the roles of LCGs in the prediction of breast cancer prognosis.
Title: Comprehensive analysis of liquid-liquid phase separation-related genes in prediction of breast cancer prognosis
Description:
Objective: Liquid-liquid phase separation (LLPS) is a functional unit formed by specific molecules.
It lacks a membrane and has been reported to play a crucial role in tumor drug resistance and growth by regulating gene expression and drug distribution.
However, whether LLPS could be used to predict cancer prognosis was not clear.
This study aimed to construct a prognostic model for breast cancer based on LLPS-correlated genes (LCGs).
Methods: LCGs were identified using the PhaSepDB, gene expression profile and clinical characteristics of breast cancer were obtained from TCGA and cBioportal.
The PanCancer Atlas (TCGA) cohort was used as the training cohort to construct the prognostic model, while the Nature 2012 and Nat Commun 2016 (TCGA) cohort and GEO data were used as test cohort to perform external verification.
Data analysis was performed with R4.
2.
0 and SPSS20.
Results: We identified 140 prognosis-related LCGs (pLCGs) (p< 0.
01) in all cohorts, 240 pLCGs (p< 0.
01) in the luminal cohort, and 28 pLCGs (p< 0.
05) in the triple-negative breast cancer (TNBC) cohort.
Twelve genes in all cohorts (training cohort: 5/10-year ROC values were 0.
76 and 0.
77; verification cohort: 5/10-year ROC values were 0.
61 and 0.
58), eight genes in the luminal cohort (training cohort: 5/10-year ROC values were 0.
79 and 0.
75; verification cohort: 5/10-year ROC values were 0.
62 and 0.
62), and four genes in the TNBC cohort (training cohort: 5/10-year ROC values were 0.
73 and 0.
79; verification cohort: 5/10-year ROC values were 0.
55 and 0.
54) were screened out to construct the prognostic prediction model.
The 17-gene risk-score was constructed in all cohorts (1/3/5-year ROC values were 0.
88, 0.
83, and 0.
81), and the 11-gene risk-score was constructed in the luminal cohort (1/3/5-year ROC values were 0.
67, 0.
85 and 0.
84), and the six-gene risk-score was constructed in the TNBC cohort (1/3/5-year ROC value were 0.
87, 0.
88 and 0.
81).
Finally, the risk-score and clinical factors were applied to construct nomograms in all cohorts (1/3/5-year ROC values were 0.
89, 0.
79 and 0.
75, C-index = 0.
784), in the luminal cohort (1/3/5-year ROC values were 0.
84, 0.
83 and 0.
85, C-index = 0.
803), and in the TNBC cohort (1/3/5-year ROC values were 0.
95, 0.
84 and 0.
77, C-index = 0.
847).
Discussion: This study explored the roles of LCGs in the prediction of breast cancer prognosis.

Related Results

Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Desmoid-Type Fibromatosis of The Breast: A Case Series
Desmoid-Type Fibromatosis of The Breast: A Case Series
Abstract IntroductionDesmoid-type fibromatosis (DTF), also called aggressive fibromatosis, is a rare, benign, locally aggressive condition. Mammary DTF originates from fibroblasts ...
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract Women with one or more first-degree female relatives with a history of breast cancer have a two-fold increased risk of developing breast cancer. This risk i...
Spanish Breast Cancer Research Group (GEICAM)
Spanish Breast Cancer Research Group (GEICAM)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Spanish Breast Cancer Research Group (GEICAM). Clinical trials...
Stable breast cancer prognosis
Stable breast cancer prognosis
AbstractPredicting breast cancer prognosis helps improve the treatment and management of the disease. In the last decades, many prediction models have been developed for breast can...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
BRDriver: Breast Cancer Driver Gene Predictor
BRDriver: Breast Cancer Driver Gene Predictor
AbstractThe breast cancer mortality rate is high in developing countries as the early detection of cancer is deficient in patients. The identification of the genes that drive cance...

Back to Top